世界の神経性過食症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bulimia Nervosa Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3947
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、神経性過食症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、心理治療、栄養療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・神経性過食症治療の市場動向
・企業の競争状況、市場シェア
・神経性過食症治療の種類別市場規模と予測2016-2027（薬物治療、心理治療、栄養療法、その他）
・神経性過食症治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・神経性過食症治療の北米市場規模2016-2027（アメリカ、カナダ）
・神経性過食症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・神経性過食症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・神経性過食症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・神経性過食症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly、AstraZeneca、Allergan、Pfizer、Bristol-Myers Squibb、Johnson&Johnson、GlaxoSmithKline）
・結論

Bulimia nervosa also known as bulimia is an eating disorder associated with binge eating that follow the compensatory procedures.

Market Analysis and Insights: Global Bulimia Nervosa Treatment Market
The global Bulimia Nervosa Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bulimia Nervosa Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bulimia Nervosa Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bulimia Nervosa Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bulimia Nervosa Treatment market.

Global Bulimia Nervosa Treatment Scope and Market Size
Bulimia Nervosa Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bulimia Nervosa Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Treatment
Psychological Treatment
Nutrition Therapy
Others

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
AstraZeneca
Allergan
Pfizer
Bristol-Myers Squibb
Johnson&Johnson
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bulimia Nervosa Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Psychological Treatment
1.2.4 Nutrition Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bulimia Nervosa Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bulimia Nervosa Treatment Market Perspective (2016-2027)
2.2 Bulimia Nervosa Treatment Growth Trends by Regions
2.2.1 Bulimia Nervosa Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bulimia Nervosa Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bulimia Nervosa Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bulimia Nervosa Treatment Industry Dynamic
2.3.1 Bulimia Nervosa Treatment Market Trends
2.3.2 Bulimia Nervosa Treatment Market Drivers
2.3.3 Bulimia Nervosa Treatment Market Challenges
2.3.4 Bulimia Nervosa Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bulimia Nervosa Treatment Players by Revenue
3.1.1 Global Top Bulimia Nervosa Treatment Players by Revenue (2016-2021)
3.1.2 Global Bulimia Nervosa Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bulimia Nervosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bulimia Nervosa Treatment Revenue
3.4 Global Bulimia Nervosa Treatment Market Concentration Ratio
3.4.1 Global Bulimia Nervosa Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bulimia Nervosa Treatment Revenue in 2020
3.5 Bulimia Nervosa Treatment Key Players Head office and Area Served
3.6 Key Players Bulimia Nervosa Treatment Product Solution and Service
3.7 Date of Enter into Bulimia Nervosa Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bulimia Nervosa Treatment Breakdown Data by Type
4.1 Global Bulimia Nervosa Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bulimia Nervosa Treatment Forecasted Market Size by Type (2022-2027)

5 Bulimia Nervosa Treatment Breakdown Data by Application
5.1 Global Bulimia Nervosa Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bulimia Nervosa Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bulimia Nervosa Treatment Market Size (2016-2027)
6.2 North America Bulimia Nervosa Treatment Market Size by Type
6.2.1 North America Bulimia Nervosa Treatment Market Size by Type (2016-2021)
6.2.2 North America Bulimia Nervosa Treatment Market Size by Type (2022-2027)
6.2.3 North America Bulimia Nervosa Treatment Market Size by Type (2016-2027)
6.3 North America Bulimia Nervosa Treatment Market Size by Application
6.3.1 North America Bulimia Nervosa Treatment Market Size by Application (2016-2021)
6.3.2 North America Bulimia Nervosa Treatment Market Size by Application (2022-2027)
6.3.3 North America Bulimia Nervosa Treatment Market Size by Application (2016-2027)
6.4 North America Bulimia Nervosa Treatment Market Size by Country
6.4.1 North America Bulimia Nervosa Treatment Market Size by Country (2016-2021)
6.4.2 North America Bulimia Nervosa Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bulimia Nervosa Treatment Market Size (2016-2027)
7.2 Europe Bulimia Nervosa Treatment Market Size by Type
7.2.1 Europe Bulimia Nervosa Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bulimia Nervosa Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bulimia Nervosa Treatment Market Size by Type (2016-2027)
7.3 Europe Bulimia Nervosa Treatment Market Size by Application
7.3.1 Europe Bulimia Nervosa Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bulimia Nervosa Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bulimia Nervosa Treatment Market Size by Application (2016-2027)
7.4 Europe Bulimia Nervosa Treatment Market Size by Country
7.4.1 Europe Bulimia Nervosa Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bulimia Nervosa Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bulimia Nervosa Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bulimia Nervosa Treatment Market Size by Type
8.2.1 Asia-Pacific Bulimia Nervosa Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bulimia Nervosa Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bulimia Nervosa Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bulimia Nervosa Treatment Market Size by Application
8.3.1 Asia-Pacific Bulimia Nervosa Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bulimia Nervosa Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bulimia Nervosa Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bulimia Nervosa Treatment Market Size by Region
8.4.1 Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bulimia Nervosa Treatment Market Size (2016-2027)
9.2 Latin America Bulimia Nervosa Treatment Market Size by Type
9.2.1 Latin America Bulimia Nervosa Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bulimia Nervosa Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bulimia Nervosa Treatment Market Size by Type (2016-2027)
9.3 Latin America Bulimia Nervosa Treatment Market Size by Application
9.3.1 Latin America Bulimia Nervosa Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bulimia Nervosa Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bulimia Nervosa Treatment Market Size by Application (2016-2027)
9.4 Latin America Bulimia Nervosa Treatment Market Size by Country
9.4.1 Latin America Bulimia Nervosa Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bulimia Nervosa Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bulimia Nervosa Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bulimia Nervosa Treatment Market Size by Type
10.2.1 Middle East & Africa Bulimia Nervosa Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bulimia Nervosa Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bulimia Nervosa Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bulimia Nervosa Treatment Market Size by Application
10.3.1 Middle East & Africa Bulimia Nervosa Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bulimia Nervosa Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bulimia Nervosa Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bulimia Nervosa Treatment Market Size by Country
10.4.1 Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Bulimia Nervosa Treatment Introduction
11.1.4 Eli Lilly Revenue in Bulimia Nervosa Treatment Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Bulimia Nervosa Treatment Introduction
11.2.4 AstraZeneca Revenue in Bulimia Nervosa Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Bulimia Nervosa Treatment Introduction
11.3.4 Allergan Revenue in Bulimia Nervosa Treatment Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bulimia Nervosa Treatment Introduction
11.4.4 Pfizer Revenue in Bulimia Nervosa Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Bulimia Nervosa Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in Bulimia Nervosa Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Johnson&Johnson
11.6.1 Johnson&Johnson Company Details
11.6.2 Johnson&Johnson Business Overview
11.6.3 Johnson&Johnson Bulimia Nervosa Treatment Introduction
11.6.4 Johnson&Johnson Revenue in Bulimia Nervosa Treatment Business (2016-2021)
11.6.5 Johnson&Johnson Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Bulimia Nervosa Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Bulimia Nervosa Treatment Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bulimia Nervosa Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Psychological Treatment
Table 4. Key Players of Nutrition Therapy
Table 5. Key Players of Others
Table 6. Global Bulimia Nervosa Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bulimia Nervosa Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bulimia Nervosa Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bulimia Nervosa Treatment Market Share by Regions (2016-2021)
Table 10. Global Bulimia Nervosa Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bulimia Nervosa Treatment Market Share by Regions (2022-2027)
Table 12. Bulimia Nervosa Treatment Market Trends
Table 13. Bulimia Nervosa Treatment Market Drivers
Table 14. Bulimia Nervosa Treatment Market Challenges
Table 15. Bulimia Nervosa Treatment Market Restraints
Table 16. Global Bulimia Nervosa Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bulimia Nervosa Treatment Market Share by Players (2016-2021)
Table 18. Global Top Bulimia Nervosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bulimia Nervosa Treatment as of 2020)
Table 19. Ranking of Global Top Bulimia Nervosa Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bulimia Nervosa Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bulimia Nervosa Treatment Product Solution and Service
Table 23. Date of Enter into Bulimia Nervosa Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bulimia Nervosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bulimia Nervosa Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Bulimia Nervosa Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bulimia Nervosa Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bulimia Nervosa Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bulimia Nervosa Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Bulimia Nervosa Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bulimia Nervosa Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bulimia Nervosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bulimia Nervosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bulimia Nervosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bulimia Nervosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bulimia Nervosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bulimia Nervosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bulimia Nervosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bulimia Nervosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bulimia Nervosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bulimia Nervosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bulimia Nervosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bulimia Nervosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bulimia Nervosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bulimia Nervosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bulimia Nervosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bulimia Nervosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bulimia Nervosa Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bulimia Nervosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bulimia Nervosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bulimia Nervosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bulimia Nervosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bulimia Nervosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bulimia Nervosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bulimia Nervosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bulimia Nervosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bulimia Nervosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bulimia Nervosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bulimia Nervosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Bulimia Nervosa Treatment Product
Table 66. Eli Lilly Revenue in Bulimia Nervosa Treatment Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Bulimia Nervosa Treatment Product
Table 71. AstraZeneca Revenue in Bulimia Nervosa Treatment Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Allergan Company Details
Table 74. Allergan Business Overview
Table 75. Allergan Bulimia Nervosa Treatment Product
Table 76. Allergan Revenue in Bulimia Nervosa Treatment Business (2016-2021) & (US$ Million)
Table 77. Allergan Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Bulimia Nervosa Treatment Product
Table 81. Pfizer Revenue in Bulimia Nervosa Treatment Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Bulimia Nervosa Treatment Product
Table 86. Bristol-Myers Squibb Revenue in Bulimia Nervosa Treatment Business (2016-2021) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Johnson&Johnson Company Details
Table 89. Johnson&Johnson Business Overview
Table 90. Johnson&Johnson Bulimia Nervosa Treatment Product
Table 91. Johnson&Johnson Revenue in Bulimia Nervosa Treatment Business (2016-2021) & (US$ Million)
Table 92. Johnson&Johnson Recent Development
Table 93. GlaxoSmithKline Company Details
Table 94. GlaxoSmithKline Business Overview
Table 95. GlaxoSmithKline Bulimia Nervosa Treatment Product
Table 96. GlaxoSmithKline Revenue in Bulimia Nervosa Treatment Business (2016-2021) & (US$ Million)
Table 97. GlaxoSmithKline Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bulimia Nervosa Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Psychological Treatment Features
Figure 4. Nutrition Therapy Features
Figure 5. Others Features
Figure 6. Global Bulimia Nervosa Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Bulimia Nervosa Treatment Report Years Considered
Figure 11. Global Bulimia Nervosa Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bulimia Nervosa Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bulimia Nervosa Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Bulimia Nervosa Treatment Market Share by Regions (2022-2027)
Figure 15. Global Bulimia Nervosa Treatment Market Share by Players in 2020
Figure 16. Global Top Bulimia Nervosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bulimia Nervosa Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bulimia Nervosa Treatment Revenue in 2020
Figure 18. Global Bulimia Nervosa Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Bulimia Nervosa Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bulimia Nervosa Treatment Market Share by Type (2016-2027)
Figure 22. North America Bulimia Nervosa Treatment Market Share by Application (2016-2027)
Figure 23. North America Bulimia Nervosa Treatment Market Share by Country (2016-2027)
Figure 24. United States Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bulimia Nervosa Treatment Market Share by Type (2016-2027)
Figure 28. Europe Bulimia Nervosa Treatment Market Share by Application (2016-2027)
Figure 29. Europe Bulimia Nervosa Treatment Market Share by Country (2016-2027)
Figure 30. Germany Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bulimia Nervosa Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bulimia Nervosa Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bulimia Nervosa Treatment Market Share by Region (2016-2027)
Figure 40. China Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bulimia Nervosa Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Bulimia Nervosa Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Bulimia Nervosa Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bulimia Nervosa Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bulimia Nervosa Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bulimia Nervosa Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bulimia Nervosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly Revenue Growth Rate in Bulimia Nervosa Treatment Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Bulimia Nervosa Treatment Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Bulimia Nervosa Treatment Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Bulimia Nervosa Treatment Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Bulimia Nervosa Treatment Business (2016-2021)
Figure 64. Johnson&Johnson Revenue Growth Rate in Bulimia Nervosa Treatment Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Bulimia Nervosa Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の非薬物式うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Free Depression Treatment Market The global Drug Free Depression Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年） Choledocholithiasis is a condition wherein gall stones are found in the common bile duct instead of the gall bladder. Market Analysis and Insights: Global Choledocholithiasis Treatment Market The global Choledocholithiasis Treatment market size is projected to reach US$ XX million by 2027, from US$ …
世界の薬物誘発性聴器毒性治療市場規模・現状・予測（2021年-2027年） Drug induced ototoxicity is defined as damage to the Cochlea and vestibule caused by the use or exposure to certain therapeutic or chemical drugs Common OTOTOXIC drugs are: aminoglycoside antibiotics, salicylic acid, quinine and loop diuretics, anti-tumor chemotherapy drugs. Market Analysis and Insi…
世界の後天性血友病治療市場規模・現状・予測（2021年-2027年） Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. Market Analysis and Insights: Global Acquired Hemophilia Treatment Market The global Acquired Hemophilia Treatment market size is projected…
世界の足底筋膜炎治療市場規模・現状・予測（2021年-2027年） Plantar fasciitis is a disorder of the connective tissue which supports the arch of the foot. It results in pain in the heel and bottom of the foot that is usually most severe with the first steps of the day or following a period of rest. Pain is also frequently brought on by bending the foot and to…